Double Blinded randomized dose escalating efficacy and safety study fo implitapide at daily doses of 10 mg, 15 mg, 20 mg, 25 mg, 30 mg, 35 mg and 40 mg compared with placebo

  • Whayne, Thomas (PI)
  • Zielke, Judy (CoI)

Grants and Contracts Details

StatusFinished
Effective start/end date11/24/046/30/05